Evidence map›Paper›PMID 41846089›Full record

ArticlePoultry science2026

High genotoxicity of CRISPR/Cas9 versus limited efficacy of CRISPRi in chicken primordial germ cells.

Chen Zhang, Mengqi Wang, Banghua He, Xianguang Yang, Xin Zhiguo Li

Abstract read
In one paragraph

Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chen ZhangCenter for RNA Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Medical School, International Institutes of Medicine, Yiwu, Zhejiang, 322000, PR China.
Mengqi WangCollege of Life Science, Henan Normal University, Xinxiang, Henan, 453007, PR China.
Banghua HeCollege of Life Science, Henan Normal University, Xinxiang, Henan, 453007, PR China.
Xianguang YangCollege of Life Science, Henan Normal University, Xinxiang, Henan, 453007, PR China.
Xin Zhiguo LiCenter for RNA Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Medical School, International Institutes of Medicine, Yiwu, Zhejiang, 322000, PR China.. Electronic address: xinlirna@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR/Cas9 technology has transformed genome editing across species; however, its application in avian germ cells remains constrained-not only by editing efficiency, but also by limited evaluation of potential genotoxic effects. In this study, we systematically assessed the performance and genomic safety of CRISPR/Cas9 and CRISPR interference (CRISPRi) in chicken primordial germ cells (PGCs). While CRISPR/Cas9 achieved high editing efficiency, it simultaneously induced substantial DNA damage, apoptosis, and sex-specific cell cycle arrest, revealing the pronounced genotoxic sensitivity of PGCs. In contrast, CRISPRi was well tolerated but failed to achieve effective gene repression in chicken cells. Comparative experiments showed that CRISPRi functioned efficiently in human 293T cells but not in chicken PGCs or somatic DF-1 cells, suggesting species-dependent limitations of mammalian-optimized repression systems. Together, these findings reveal a fundamental trade-off-"efficient but toxic" versus "safe but ineffective"-when applying CRISPR tools to avian germ cells. Our results highlight the need for species-adapted, low-toxicity genome-editing platforms in poultry and provide a framework for evaluating editing strategies in developmentally sensitive cell types.

Indexed as

ChickensCRISPR-Cas SystemsDNA DamageGene EditingGerm CellsAnimalsFemaleHumansMaleChickenCRISPR/Cas9CRISPR interferenceGenotoxicityPrimordial germ cell

Identifiers

PMID41846089
PMCPMC13011053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.